Trial Details

RECRUITING
Basic Information
Clinical ID c2
Identifier NCT05753267
Trial Title Fenofibrate in Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Inflammatory Bowel Diseases
Interventions DRUG: Mesalamine|DRUG: Fenofibrate 160mg
Participant Information
Sponsor Tanta University
City Tanta
Country/Region Egypt
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE2|PHASE3
Time Information
Start Date 2023-02-28
Primary Completion Date 2026-02-20
Completion Date 2026-06-20